Skip to main content
. Author manuscript; available in PMC: 2017 Jun 15.
Published in final edited form as: Cancer. 2016 Apr 8;122(12):1928–1936. doi: 10.1002/cncr.29987

Table 2.

Subsequent treatments in 27 NF1 patients who received 1–3 other chemotherapy regimens after CV and # with subsequent malignant neoplasms (SMN).

Subsequent Treatments # Patients # SMN
PCV or TPCV 4 0
Temozolomide 9 2
Temozolomide + thalidomide 1 1
Carboplatin + Vincristine 5 0
Vinblastine 6 0
Radiation 8 0
Rapamycin 2 0
Lenalidomide 2 0
Thalidomide 1 0
Etoposide 2 0
Cyclophosphamide + celecoxib 1 0